600
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Stent design matters: insights from virtual bench testing

&
Pages 613-615 | Published online: 10 Jan 2014

References

  • Kastrati A, Dirschinger J, Boekstegers P et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1147 unselected patients. Cathet. Cardiovasc. Intervent.50(3), 290–297 (2000).
  • Kastrati A, Mehilli J, Dirschinger J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation103(23), 2816–2821 (2001).
  • Stone GW, Midei M, Newman W et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the clinical evaluation of the Xience V everolimus-eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions (SPIRIT) III trial. Circulation119(5), 680–686 (2009).
  • Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation91(12), 2995–3001 (1995).
  • Verdonck P. The role of computational fluid dynamics for artificial organ design. Artif. Organs26(7), 569–570 (2002).
  • Mortier P, Holzapfel GA, De Beule M et al. A novel simulation strategy for stent insertion and deployment in curved coronary bifurcations: comparison of three drug-eluting stents. Ann. Biomed. Eng.38(1), 88–99 (2010).
  • Liu X, Tsujita K, Maehara A et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc. Interv.2(10), 997–1004 (2009).
  • Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med.349(14), 1315–1323 (2003).
  • Slager CJ, Wentzel JJ, Schuurbiers JC et al. True 3-dimensional reconstruction of coronary arteries in patients by fusion of angiography and IVUS (ANGUS) and its quantitative validation. Circulation102(5), 511–516 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.